Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The SGLT2 inhibitor dapagliflozin in heart failure with p... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
0
Authors
Michael Nassif
25 more
Michael Nassif
•
Sheryl Windsor
23 more
•
Mikhail Kosiborod
Published
October 28, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Cardiology
Show all topics
DOI
10.1038/s41591-021-01536-x
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Cardiology
Show all topics
DOI
10.1038/s41591-021-01536-x
License
CC-BY
Other Formats
PDF
